YDES
YD Bio Limited Ordinary Shares
There isn't enough reported data to score YDES yet.
YDES Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
YDES's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
YDES PE Valuation
YDES has no meaningful PE right now: it lost money over the past year.
YDES Forward outlook
There aren't enough analyst estimates for YDES to show an outlook.
YDES Earnings Per Share
YDES Quarterly Revenue
YDES Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$365.7K | +$322.8K |
YDES Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -100% | -4M shares |
| 1 year | -100% | -4.3M shares |
YDES has 1,000 diluted shares, down 100% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $3.1M |
| Q1 2024 | — |
| Q4 2023 | — |
YDES Net Leverage
YDES's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
YDES Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.8 | Neutral |
| Stochastic | 56.6 | Neutral |
YDES's weekly RSI is 50 (neutral) and its Stochastic is 57 (neutral).
YDES PE vs Healthcare Sector
YDES has no meaningful PE right now: it lost money over the past year.
YDES Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.07 | 14% below |
| 20 week MA | $4.25 | 22% above |
| 50 week MA | $6.42 | 19% below |
YDES's trend is mixed: it's above one of its three weekly moving averages, and 19% below its 50-week average.
YDES Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $12.1 | $12.2 | +1.2% |
| 2026 YTD | $12.2 | $5.20 | -58% |
YDES has finished every year since 2025 higher, and it's down 58% so far in 2026.